Ticker Details
Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients.
IPO Date:	February 22, 2000
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$278.83M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 3.86%
Avg Daily Range (30 D):	$0.20 | 2.98%
Avg Daily Range (90 D):	$0.20 | 2.95%

Institutional Daily Volume
Avg Daily Volume:	5.12M
Avg Daily Volume (30 D):	.42M
Avg Daily Volume (90 D):	.41M

Trade Size
Avg Trade Size (Sh.):	442
Avg Trade Size (Sh.) (30 D):	98
Avg Trade Size (Sh.) (90 D):	97

Institutional Trades
Total Institutional Trades:	443
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$.62M
Avg Institutional Trade (90 D):	$1.34M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.41M
Avg Closing Trade (30 D):	$2.79M
Avg Closing Trade (90 D):	$2.79M
Avg Closing Volume:	82.35K

News

Mar 27, 2026 @ 2:15 PM MedTech's Edge: How AI and Remote Diagnostics Driv... Source: Equity Insider

Mar 14, 2026 @ 2:15 PM First Ever Real-World Evidence of Eversense 365 Pr... Source: Senseonics Holdings, Inc.

Oct 7, 2025 @ 5:17 PM Senseonics Tumbles As Q3 Results And Split Hit Sto... Source: Lekha Gupta

May 21, 2025 @ 9:06 PM Senseonics Holdings, Inc. Announces Closing of Pub... Source: N/A

May 21, 2025 @ 5:47 PM Diabetic Care Device Market Set for Significant Gr... Source: Bcc Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.66	$-.47	$-1.66
Diluted EPS	$-1.66	$-.47	$-1.66
Revenue	$35.26M	$14.26M	$35.26M
Gross Profit	$15.76M	$7.67M	$15.76M
Net Income / Loss	$-69.11M	$-20.82M	$-69.11M
Operating Income / Loss	$-68.34M	$-20.93M	$-68.34M
Cost of Revenue	$19.49M	$6.59M	$19.49M
Net Cash Flow	$-34.36M	$5.78M	$-34.36M
PE Ratio

Splits
Oct 20, 2025	1:20
Nov 10, 2015	12:1